3-iodobenzylguanidine has been researched along with von Hippel-Lindau Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boju, SL; Guptha, R; Kalawat, TC; Kumar, AV; Mogili, HK; R, R; V, SK | 1 |
| Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kaji, P; Lai, EW; Linehan, WM; Pacak, K; Pinto, PA | 1 |
| Alexakis, N; Neoptolemos, JP | 1 |
| Bringer, J; Faurous, P; Jaffiol, C; Pujol, P | 1 |
| Hayakawa, N; Kataoka, H; Makino, H; Nakagawa, M; Ogura, T; Oishi, T; Otsuka, F | 1 |
| Chao, DL; Chen, MY; Chew, EY; Oldfield, EH; Reynolds, JC | 1 |
1 review(s) available for 3-iodobenzylguanidine and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Pancreatic neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Hormones; Humans; Liver Neoplasms; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed; von Hippel-Lindau Disease | 2008 |
5 other study(ies) available for 3-iodobenzylguanidine and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Pheochromocytoma of Urinary Bladder in a Dialysis PatientPheochromocytoma of Urinary Bladder.
Topics: 3-Iodobenzylguanidine; Adult; Antihypertensive Agents; Biopsy; Blood Pressure; Carcinoma, Renal Cell; Cystectomy; Drug Therapy, Combination; Humans; Hypertension; Iodine Radioisotopes; Kidney Neoplasms; Male; Nephrectomy; Pheochromocytoma; Radiopharmaceuticals; Renal Dialysis; Treatment Outcome; Urinary Bladder Neoplasms; von Hippel-Lindau Disease | 2017 |
The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dopamine; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease | 2007 |
Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Bone Neoplasms; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lung Neoplasms; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Time Factors; von Hippel-Lindau Disease | 1995 |
Normotensive bilateral pheochromocytoma with Lindau disease: case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Blood Pressure; Catecholamines; Cerebellar Neoplasms; Hemangioblastoma; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Tomography, X-Ray Computed; von Hippel-Lindau Disease | 1996 |
Metastatic brainstem pheochromocytoma in a patient with von Hippel-Lindau disease. Case illustration.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Brain Neoplasms; Brain Stem; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; von Hippel-Lindau Disease | 2001 |